bioRxiv Science⌕ Search

Biology subjects

Mason, M. J.

Publications and source records attributed to Mason, M. J..

3 recordsLinked to original sources

A model for maxilloturbinate morphogenesis in seals

The nasal cavities of mammals contain the maxilloturbinate bones, which are involved in respiratory heat and humidity regulation. The maxilloturbinates of Arctic seals develop into particularly elaborate labyrinthine patterns, which are well adapted to retain heat and moisture from exhaled gas. These structures develop prenatally and continue to grow postnatally. The developmental mechanism of labyrinthine patterning is unknown. Here we report a model of maxilloturbinate pattern formation in prenatal and juvenile seals based on a simple algorithmic description and three key parameters: target turbinate porosity, characteristic ossification time scale, and typical gestation time scale. Under a small set of geometrical and physical rules, our model reproduces key features of the patterns observed in grey and harp seal turbinates, and even in the less complex monk seal turbinates. To validate our model, we measure complexity, hydraulic diameter, backbone fractal dimension, and Horton-Strahler statistics for a rigorous quantitative comparison with actual tomograms of grey and harp seal skull specimens. Our model closely replicates the structural development of seal turbinates in these respects. Labyrinthine maxilloturbinate development likely requires the ability for neighbouring bone branches to detect and avoid each other through the mechanosensing of shear stresses from amniotic fluid and air flow.

developmental biology↗

Crowdsourced mapping of unexplored target space of kinase inhibitors

Despite decades of intensive search for compounds that modulate the activity of particular targets, there are currently small-molecules available only for a small proportion of the human proteome. Effective approaches are therefore required to map the massive space of unexplored compound-target interactions for novel and potent activities. Here, we carried out a crowdsourced benchmarking of predictive models for kinase inhibitor potencies across multiple kinase families using unpublished bioactivity data. The top-performing predictions were based on kernel learning, gradient boosting and deep learning, and their ensemble resulted in predictive accuracy exceeding that of kinase activity assays. We then made new experiments based on the model predictions, which further improved the accuracy of experimental mapping efforts and identified unexpected potencies even for under-studied kinases. The open-source algorithms together with the novel bioactivities between 95 compounds and 295 kinases provide a resource for benchmarking new prediction algorithms and for extending the druggable kinome.

biochemistry↗

Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator PHF19 As Marker of Aggressive Disease

While the past decade has seen meaningful improvements in clinical outcomes for multiple myeloma patients, a subset of patients do not benefit from current therapeutics for unclear reasons. Many gene expression-based models of risk have been developed, but each model uses a different combination of genes and often involve assaying many genes making them difficult to implement. We organized the Multiple Myeloma DREAM Challenge, a crowdsourced effort to develop models of rapid progression in newly diagnosed myeloma patients and to benchmark these against previously published models. This effort lead to more robust predictors and found that incorporating specific demographic and clinical features improved gene expression-based models of high risk. Furthermore, post challenge analysis identified a novel expression-based risk marker and histone modifier, PHF19, which featured prominently in several independent models. Lastly, we show that a simple four feature predictor composed of age, International Staging System stage (ISS), and expression of PHF19 and MMSET performs similarly to more complex models with many more gene expression features included.\n\nKey pointsO_LIMost comprehensive and unbiased assessment of prognostic biomarkers in MM resulting in a robust and parsimonious model.\nC_LIO_LIIdentification of PHF19 as the expression based biomarker most strongly associated with rapid progression in MM patients.\nC_LI

cancer biology↗